AdvanSource Biomaterials to Be Delisted from NYSE Amex and Intends to Trade on OTCBB

WILMINGTON, Mass.--(BUSINESS WIRE)--AdvanSource Biomaterials Corporation (NYSE Amex: ASB), a leading developer, manufacturer and seller of advanced polymer technologies and materials for a broad range of medical devices, today announced it was notified by the NYSE Amex of its intent to delist the Company’s common stock if an appeal is not submitted by November 16, 2010. Rather than appeal, the Company intends to qualify its common stock for trading on the Over-the-Counter Bulletin Board.

Back to news